May 11 (SeeNews) - North Macedonia-based drug maker Replek [MSE:REPL] said that its consolidated net profit reached 76.8 million denars ($1.5 million/1.2 million euro) in the first quarter of 2021, compared with a 30.2 million denars profit booked in the like period a year earlier.